Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide
PHASE2CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
April 30, 2014
Primary Completion Date
August 17, 2016
Study Completion Date
August 17, 2017
Conditions
Relapsed or Refractory Multiple Myeloma
Interventions
DRUG
Imnovid (pomalidomide)
DRUG
Dexamethasone
DRUG
Endoxan (Cyclophosphamide)
Trial Locations (1)
Unknown
University Hospital, Tübingen
All Listed Sponsors
lead
University Hospital Tuebingen
OTHER
NCT02046915 - Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide | Biotech Hunter | Biotech Hunter